[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"trial:NCT05820672":3,"trial-entities:NCT05820672":259,"trial-summary:NCT05820672":262},{"id":4,"nct_id":4,"org_study_id":5,"brief_title":6,"official_title":7,"overall_status":8,"completion_date":9,"status_verified_date":10,"last_update_date":11,"start_date":12,"sponsor_name":13,"lead_sponsor_class":14,"has_dmc":15,"brief_summary":16,"detailed_description":17,"conditions":18,"keywords":20,"study_type":23,"primary_purpose":24,"phases":25,"enrollment_info":26,"interventions":29,"primary_outcomes":35,"secondary_outcomes":43,"sex":49,"minimum_age":24,"maximum_age":24,"healthy_volunteers":15,"eligibility_criteria":50,"std_ages":58,"locations":62,"central_contacts":246,"overall_officials":252,"references":257,"see_also_links":258},"NCT05820672","ASND0037","A US Non-interventional, Effectiveness and Safety Study of Patients Treated With SKYTROFA","A US Multi-center, Prospective, Non-interventional, Long Term, Effectiveness and Safety Study of Patients Treated With SKYTROFA (Lonapegsomatropin)","RECRUITING","2033-03","2026-04","2026-04-21","2023-03-20","Ascendis Pharma Endocrinology Division A\u002FS","INDUSTRY",false,"The goal of this study is to genrate evidence on long-term effectiveness and safety of SKYTROFA (lonapegsomatropin) in patients with growth hormone deficiency under routine clinical care","Patients will be treated according to routine clinical practice, and no additional visits, examinations or tests will be required beyond those performed as part of routine clinical practice except for COAs.",[19],"Growth Hormone Deficiency",[21,22],"Human Growth Hormone","SKYTROFA","OBSERVATIONAL",null,[],{"count":27,"type":28},900,"ESTIMATED",[30],{"type":31,"name":32,"description":32,"armGroupLabels":33},"OTHER","No intervention",[34],"Patients on SKYTROFA Treatment",[36,40],{"measure":37,"description":38,"timeFrame":39},"Assess the safety of patients treated with SKYTROFA (Lonapegsomatropin)","Incidence of Adverse Events and Serious Adverse Events","5 years",{"measure":41,"description":42,"timeFrame":39},"Assess the effectiveness of patients treated with SKYTROFA (Lonapegsomatropin)","Near adult height (cm)",[44,47],{"measure":45,"description":46,"timeFrame":39},"Assess clinical outcome assessments (COAs)","Change in Quality of Life in Short Stature Youth (QoLISSY) scores from baseline through End of Study (QOLISSY scores range on a scale of 0 to 100 with higher scores representing better quality of life. (For both child and parent version))",{"measure":45,"description":48,"timeFrame":39},"Change in Treatment Satisfaction Questionnaire for Medicine (TSQM-9) scores from baseline through End of Study (The TSQM-9 domain scores range from 0 to 100 with higher scores representing higher satisfaction on that domain)","ALL",{"inclusion":51,"exclusion":55,"raw_text":57},[52,53,54],"Patients who are on treatment with SKYTROFA (lonapegsomatropin)","Patients being clinically managed in USA","Patients with an appropriate written informed consent\u002Fassent as applicable for the age of the patient",[56],"Patients participating in any interventional clinical study","Inclusion Criteria:\n\n* Patients who are on treatment with SKYTROFA (lonapegsomatropin)\n* Patients being clinically managed in USA\n* Patients with an appropriate written informed consent\u002Fassent as applicable for the age of the patient\n\nExclusion Criteria:\n\n* Patients participating in any interventional clinical study",[59,60,61],"CHILD","ADULT","OLDER_ADULT",[63,72,79,85,91,99,106,113,116,122,129,136,143,150,157,164,171,178,184,191,198,205,212,219,226,232,239],{"facility":64,"status":8,"city":65,"state":66,"zip":67,"country":68,"geoPoint":69},"Ascendis Investigational Site","Phoenix","Arizona","85054","United States",{"lat":70,"lon":71},33.44838,-112.07404,{"facility":64,"status":8,"city":73,"state":74,"zip":75,"country":68,"geoPoint":76},"Orange","California","92868",{"lat":77,"lon":78},33.78779,-117.85311,{"facility":64,"status":8,"city":80,"state":74,"zip":81,"country":68,"geoPoint":82},"Sacramento","95821",{"lat":83,"lon":84},38.58157,-121.4944,{"facility":64,"status":8,"city":86,"state":74,"zip":87,"country":68,"geoPoint":88},"San Francisco","94143",{"lat":89,"lon":90},37.77493,-122.41942,{"facility":92,"status":8,"city":93,"state":94,"zip":95,"country":68,"geoPoint":96},"Ascendis Pharma Investigational Site","Centennial","Colorado","80112",{"lat":97,"lon":98},39.57916,-104.87692,{"facility":64,"status":8,"city":100,"state":101,"zip":102,"country":68,"geoPoint":103},"Washington D.C.","District of Columbia","20010",{"lat":104,"lon":105},38.89511,-77.03637,{"facility":64,"status":8,"city":107,"state":108,"zip":109,"country":68,"geoPoint":110},"Orlando","Florida","32806",{"lat":111,"lon":112},28.53834,-81.37924,{"facility":64,"status":8,"city":107,"state":108,"zip":114,"country":68,"geoPoint":115},"32827",{"lat":111,"lon":112},{"facility":64,"status":8,"city":117,"state":108,"zip":118,"country":68,"geoPoint":119},"Tampa","33612",{"lat":120,"lon":121},27.94752,-82.45843,{"facility":64,"status":8,"city":123,"state":124,"zip":125,"country":68,"geoPoint":126},"Sandy Springs","Georgia","30350",{"lat":127,"lon":128},33.92427,-84.37854,{"facility":64,"status":8,"city":130,"state":131,"zip":132,"country":68,"geoPoint":133},"Boise","Idaho","83712",{"lat":134,"lon":135},43.6135,-116.20345,{"facility":64,"status":8,"city":137,"state":138,"zip":139,"country":68,"geoPoint":140},"Indianapolis","Indiana","46202",{"lat":141,"lon":142},39.76838,-86.15804,{"facility":64,"status":8,"city":144,"state":145,"zip":146,"country":68,"geoPoint":147},"Iowa City","Iowa","52242",{"lat":148,"lon":149},41.66113,-91.53017,{"facility":64,"status":8,"city":151,"state":152,"zip":153,"country":68,"geoPoint":154},"Louisville","Kentucky","40202",{"lat":155,"lon":156},38.25424,-85.75941,{"facility":64,"status":8,"city":158,"state":159,"zip":160,"country":68,"geoPoint":161},"Minneapolis","Minnesota","55455",{"lat":162,"lon":163},44.97997,-93.26384,{"facility":64,"status":8,"city":165,"state":166,"zip":167,"country":68,"geoPoint":168},"Las Vegas","Nevada","89113",{"lat":169,"lon":170},36.17497,-115.13722,{"facility":64,"status":8,"city":172,"state":173,"zip":174,"country":68,"geoPoint":175},"Lebanon","New Hampshire","03756",{"lat":176,"lon":177},43.64229,-72.25176,{"facility":64,"status":8,"city":179,"state":173,"zip":180,"country":68,"geoPoint":181},"Manchester","03104",{"lat":182,"lon":183},42.99564,-71.45479,{"facility":64,"status":8,"city":185,"state":186,"zip":187,"country":68,"geoPoint":188},"Morristown","New Jersey","07960",{"lat":189,"lon":190},40.79677,-74.48154,{"facility":64,"status":8,"city":192,"state":193,"zip":194,"country":68,"geoPoint":195},"New Hyde Park","New York","11042",{"lat":196,"lon":197},40.7351,-73.68791,{"facility":64,"status":8,"city":199,"state":200,"zip":201,"country":68,"geoPoint":202},"Cincinnati","Ohio","45229",{"lat":203,"lon":204},39.12711,-84.51439,{"facility":64,"status":8,"city":206,"state":207,"zip":208,"country":68,"geoPoint":209},"Portland","Oregon","97239",{"lat":210,"lon":211},45.52345,-122.67621,{"facility":64,"status":8,"city":213,"state":214,"zip":215,"country":68,"geoPoint":216},"Columbia","South Carolina","29203",{"lat":217,"lon":218},34.00071,-81.03481,{"facility":64,"status":8,"city":220,"state":221,"zip":222,"country":68,"geoPoint":223},"Dallas","Texas","75390",{"lat":224,"lon":225},32.78306,-96.80667,{"facility":64,"status":8,"city":227,"state":221,"zip":228,"country":68,"geoPoint":229},"El Paso","79907",{"lat":230,"lon":231},31.75872,-106.48693,{"facility":64,"status":8,"city":233,"state":234,"zip":235,"country":68,"geoPoint":236},"Norfolk","Virginia","23507",{"lat":237,"lon":238},36.84681,-76.28522,{"facility":64,"status":8,"city":240,"state":241,"zip":242,"country":68,"geoPoint":243},"Seattle","Washington","98105",{"lat":244,"lon":245},47.60621,-122.33207,[247],{"name":248,"role":249,"phone":250,"email":251},"Deborah Bowlby","CONTACT","+1 844-442-7236","Skybright_contact@ascendispharma.com",[253],{"name":254,"affiliation":255,"role":256},"Medical Director, MD","Ascendis Pharma A\u002FS","STUDY_DIRECTOR",[],[],{"nct_id":4,"conditions":260,"biomarkers":261},[19],[],{"nct_id":4,"found":263,"summary":264,"prompt_version":274},true,{"design":265,"status":266,"heading":267,"summary":268,"follow_up":269,"word_count":270,"commitments":271,"compensation":272,"drugs_mentioned":273},"This is an observational study with a planned enrollment of 900 participants. It is not a randomized trial, and there is no specified phase.","completed","Observational Study of SKYTROFA for Growth Hormone Deficiency","This study is looking at how well and how safely SKYTROFA (lonapegsomatropin) works for people with growth hormone deficiency in their everyday medical care. It's an observational study, meaning you would receive SKYTROFA as part of your usual treatment, and researchers would collect information from your medical records. The study aims to understand the long-term effectiveness and safety of SKYTROFA over five years. You can join if you are already being treated with SKYTROFA, are managed by a doctor in the USA, and provide your consent. The study is currently unclear on its recruitment status.","The safety and effectiveness of SKYTROFA will be assessed over 5 years.",95,"You will be treated according to your routine clinical practice. No extra visits, exams, or tests are required beyond what your doctor normally does, except for COAs (Clinical Outcome Assessments).","Not stated in the trial record.",[],"v2"]